Vita Life Sciences Limited · ASX:VLS
Vita Life Sciences — Shareholder Meeting (May 2019)
25 slides from Vita Life Sciences's shareholder meeting presentation, May 31, 2019
Slide 1: Annual General Meeting, 31 May 2019
For personal use only 31 May 2019
Slide 2: Agenda
AGENDA For personal use only 1. Chairman’s Welcome Address 2. Managing Director’s Review 3. Ordinary Resolutions 4. Question & Answer 2
Slide 3: Agenda
AGENDA For personal use only 1. Chairman’s Welcome Address 2. Managing Director’s Review 3. Ordinary Resolutions 4. Question & Answer 3
Slide 4: For personal use only
Australian & Asia Pacific based pharmaceutical and healthcare over the-counter business involved in the formulating, packaging, sales and distribution of vitamins and supplements For personal use only 3 major consumer retail brands 750-800 registered SKUs of vitamins and supplements sold in 7 countr
Slide 5: Financial Summary
FINANCIAL SUMMARY SALES EBIT* For personal use only Group sales of $41.1 million for the financial year (FY) ended Dec 2018, an increase of 10.6% over the previous corresponding period ($’m) ($’m) ($’m) (PCP) of $37.2 million 45 7 40 6 The Group recorded an underlying EBIT of $6.2m (excluding a non-
Slide 6: Full Year 2018 Results
FULL YEAR 2018 RESULTS For personal use only 2018 revenue by geography 2017 revenue by geography Other Asia Other Asia 6% 7% Australia Australia Singapore 41% Singapore 41% 17% 17% Asia Asia 59% 59% Malaysia Malaysia 35% 36% Total revenue: $41.1m Total revenue: $37.2m 6
Slide 7: Segment Results: Australia
SEGMENT RESULTS Sales ($’m) AUSTRALIA 16.0 For personal use only 12.0 H2 H2 Sales: $16.4m (2017: $15.6m) 8.0 Revenue from the Health food market grew marginally despite channel contraction 4.0 H1 H1 Moderate increase in export sales from Australia to China through the “daigou” channel - 2018 201
Slide 8: Herbs of Gold 'Golden Formula' Campaign Television
HERBS OF GOLD ‘GOLDEN FORMULA’ CAMPAIGN TELEVISON For personal use only https://www.youtube.com/watch ?v=5y6Kv2fTjIE 8
Slide 9: Herbs of Gold 'Golden Formula' Campaign Outdoor
HERBS OF GOLD ‘GOLDEN FORMULA’ CAMPAIGN OUTDOOR For personal use only 9
Slide 10: Segment Results: Malaysia
SEGMENT RESULTS Sales ($’m) MALAYSIA 16 For personal use only 12 H2 Sales $14.9m (2017: $12.9m) H2 Revenue base increased by 15.5% due to expanded 8 consumer campaign 4 H1 Increased distribution of the VitaHealth brand through major H1 chain pharmay groups including Watsons and Guardian 0 Herb
Slide 11: VitaHealth Brand Refresh
VITAHEALTH BRAND REFRESH For personal use only New websites across all VitaHealth SEA markets New packaging & labels New brand identity 11
Slide 12: Segment Results: Singapore
SEGMENT RESULTS Sales ($’m) SINGAPORE For personal use only 6 Sales $6.9m (2017: $6.3m) H2 H2 Revenue base business was sustained generating marginal 4 growth on (PCP) Increased trade investment was required to maintain sales 2 momentum H1 H1 Solid performance considering the market conditions
Slide 13: Segment Results: Others
SEGMENT RESULTS OTHERS For personal use only Sales $2.9m (2017: $2.4m) Sales ($’m) Revenue in other markets growth of 19% (PCP) Stronger sales were recorded for Vietnam with marginal improvement in Thailand compared to the PCP H2 2 Vietnam continues to perform to expectation and is H2 expected
Slide 14: Strategic Priorities & Outlook
STRATEGIC PRIORITIES & OUTLOOK For personal use only 2018 was the second of a three year strategic plan set to grow long term revenues Increased advertising and promotional investment in core markets is reflected in the 2018 results and will continue into 2019 Increase brand investment may impact pr
Slide 15: Strategic Priorities & Outlook
STRATEGIC PRIORITIES & OUTLOOK For personal use only First half FY2019 sales of around $20m will be in line with the corresponding period. Whilst we have had a positive impact from the new Pharmacy channel, this has been offset by slightly lower sales from the traditional Health food channel First h
Slide 16: Agenda
AGENDA For personal use only 1. Chairman’s Welcome Address 2. Managing Director’s Review 3. Ordinary Resolutions 4. Question & Answer 16
Slide 17: Ordinary Resolutions
ORDINARY RESOLUTIONS For personal use only 1. Remuneration Report 2. Re-election of Director - Mr Vanda Gould 3. Share Buy-Back 4. Long Term Incentive Plan- Mr Henry Townsing 5. Approval for an Equal Reduction of Capital 6. Removal of Russell Bedford NSW as auditors 7. Confirmation of Appointment of
Slide 18: Proxy
PROXY PROXY’S RESOLUTIONS IN FAVOUR AGAINST ABSTAIN TOTALS DISCRETION For personal use only 1) Adoption of the Remuneration Report 8,269,363 34,478 8,292,989 20,434,720 37,031,550 2) Re-election of Director 18,599,516 25,760 8,292,989 10,113,285 37,031,550 (Mr Vanda Gould) 3) Share Buy-Back 28,728,1
Slide 19: Agenda
AGENDA For personal use only 1. Chairman’s Welcome Address 2. Managing Director’s Review 3. Ordinary Resolutions 4. Question & Answer 19
Slide 20: Thank You
THANK YOU For personal use only Contact: Telephone: +61 2 9545 2633 Website: vitalifesciences.com.au Email: enquiries@vitalifesciences.com.au Head Office: 1/ 102 Bath Road, Kirrawee, NSW 2232 20
Slide 21: Appendix
For personal use only APPENDIX 21
Slide 22: Appendix – Profit & Loss
APPENDIX 1 – PROFIT & LOSS For personal use only 2018 2017 Full year ended Dec $’m $’m Revenue 41.1 37.2 EBITDA 6.6 5.0 EBIT 4.4 4.7 Profit before tax 4.3 4.7 Profit after tax 2.4 2.8 EPS (Basic – cents/ share) 4.44 5.21 Dividend (cents / share) 3.75 3.75 22
Slide 23: Appendix – Balance Sheet
APPENDIX 2 – BALANCE SHEET For personal use only Dec 2018 Dec 2018 Balance Sheet as at $’m $’m Current assets 24.8 22.3 Non-current assets 10.9 10.6 Total assets 35.7 32.9 Current liabilities 11.4 6.0 Non-current liabilities 1.9 2.1 Total Liabilities 13.3 8.1 Net Assets 22.4 24.8 23
Slide 24: Appendix – Cash Flow
APPENDIX 3 – CASH FLOW 2018 2017 For personal use only Cash Flow for the year ended $’m $’m Receipts from customers 44.6 40.8 Payments to suppliers and employees 38.1 34.8 Gross operating cash flow 6.5 6.0 Adjusted EBITDA (ex fair value loss adjt & share options exp) 6.6 6.0 Gross operating cash flo
Slide 25: Disclaimer
DISCLAIMER For personal use only This document has been prepared by Vita Life Sciences Limited (Vita Life Sciences) and comprises written material/slides for a presentation concerning Vita Life Sciences. The presentation is for information purposes only and does not constitute or form part of any of